Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Researchers from a wide range of disciplines have been appointed to be the next cohort of NIHR Oxford Senior Research Fellows - seven mid-career researchers identified as having the potential to become future translational research leaders. The cohort includes Dr Matthias Friedrich from the Translational Gastroenterology Unit in NDM’s Experimental Medicine Division.

As in previous years, the selection process was a coordinated effort by the NIHR Oxford Biomedical Research Centre (BRC) and its partners in the NIHR Oxford Health BRC and the NIHR Applied Research Collaboration (ARC) for Oxford and the Thames Valley. This is the fourth cohort of Senior Research Fellows to be appointed since the scheme was launched in 2019.

Dr Matthias Friedrich is a Group leader in NDM’s Experimental Medicine Division. He investigates the cellular and molecular mechanisms of chronic inflammation and fibrosis (Oxford BRC Inflammation Theme). The Senior Fellows, who were selected by an expert panel, will receive an award of £5,000 a year for two years that may be used flexibly to facilitate their translational research programme and career development.

The fellowship offers them mentoring, coaching and networking opportunities, as well as supporting them to advance an independent research area which will enhance NIHR research in Oxford and strengthen future funding applications.

Dr Friedrich said: ‘I am delighted to be awarded a NIHR senior research fellowship, which will mean a huge boost to my professional development. The NIHR SRF represents a unique source of flexible funding in addition to conventional research funding, enabling me to enhance key skills and infrastructure. I am planning to use the fellowship to train in leadership, management, and trial design and to strengthen my national and international links. This training will impact many aspects of my translational research programme and will allow me to further build and improve my team of researchers and collaborators. I’m looking forward to being part of the NIHR family!’

Along with Dr Friedrich, the other appointed Senior Research Fellows are Dr Nicola Curry from the Radcliffe Department of Medicine; Dr Dimitrios Koutoukidis from the Nuffield Department of Primary Care Health Sciences; Dr Katy Vincent from the Nuffield Department of Women’s and Reproductive Health; Dr Ludovica Griffanti from the Wellcome Centre for Integrative Neuroimaging (WIN); Dr Lucy Foulkes from the Department of Experimental Psychology; and Dr Jiedi Lei from the Oxford Health BRC Mental Health in Development Theme.

For more details read the NIHR news.

Similar stories

Rift Valley fever vaccine to enter Phase II clinical trials in Kenya

A promising human vaccine candidate against the potentially deadly Rift Valley fever, a mosquito-borne disease affecting countries across Africa, is set to begin Phase II trials in Kenya. This is the most advanced stage of testing a human Rift Valley fever vaccine has reached in an outbreak-prone area to date. A team of scientists at the Nuffield Department of Medicine and the KEMRI-Wellcome Trust Research Programme will lead the $3.7m trial, funded by the Coalition for Epidemic Preparedness Innovations (CEPI).